We investigated potential effects of MSLN on chemoresistance and various biological processes in pancreatic cancer cells such as proliferation, metastasis, EMT and cancer stem cell traits so as to provide a new idea for chemotherapy and targeted therapy of pancreatic cancer. This evidence concerns the gene MSLN and pancreatic neoplasm.